Insta

Gujarat: Bharat Biotech Begins Commercial Roll Out Of Covaxin From New Facility In Ankleshwar

Swarajya Staff

Aug 30, 2021, 08:57 AM | Updated 08:57 AM IST


Source: Financial Express
Source: Financial Express

In a big boost towards augmenting the production capacity of the nation's first indigenously developed COVID-19 vaccine Covaxin, Hyderabad-based Bharat Biotech has rolled out the first commercial batch from its Chiron Behring Vaccines facility in Gujarat's Ankleshwar, reports Times of India.

With the production having begun at the facility which was built during 2020, supplies will now begin from here in September. It should be noted that the production had begun there in early June itself, before which the team from Bharat Biotech had executed engineering batches to study the equipment functionality at the facility.

The first batch was launched by Union Minister for Health and Family Welfare Mansukh Mandaviya.

Covaxin, along with Covishield has been widely used as a part of the Government's nationwide COVID-19 vaccination programme so far. It has been developed by Dr Krishna Ella-led Bharat Biotech in association with the Indian Council for Medical Research (ICMR) and Pune-based National Institute of Virology.


Get Swarajya in your inbox.


Magazine


image
States